Rula Amarin

465 total citations
30 papers, 233 citations indexed

About

Rula Amarin is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Rula Amarin has authored 30 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Rula Amarin's work include Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Rula Amarin is often cited by papers focused on Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Rula Amarin collaborates with scholars based in Jordan, United States and Lebanon. Rula Amarin's co-authors include Dhrubajyoti Bandyopadhyay, Raja Zaghlol, Amit K. Dey, Kirolos Barssoum, Carl J. Lavie, Deepak L. Bhatt, Akram Al‐Ibraheem, Rowa’ Al-Ramahi, Maher A. Sughayer and Nathan Bahary and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Rula Amarin

25 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rula Amarin Jordan 7 78 56 46 35 34 30 233
Ana Terezinha Marques Mesquita Brazil 10 34 0.4× 35 0.6× 27 0.6× 46 1.3× 55 1.6× 29 254
Chi‐Kuang Young Taiwan 12 34 0.4× 80 1.4× 14 0.3× 83 2.4× 23 0.7× 23 277
J.M. Bonnetblanc France 10 75 1.0× 10 0.2× 63 1.4× 32 0.9× 69 2.0× 20 247
Gezmiş Kimyon Türkiye 11 34 0.4× 17 0.3× 56 1.2× 18 0.5× 42 1.2× 36 278
E D'Amico Italy 11 91 1.2× 6 0.1× 98 2.1× 27 0.8× 57 1.7× 22 343
Krzysztof Piersiala Sweden 9 16 0.2× 63 1.1× 25 0.5× 55 1.6× 9 0.3× 35 266
Harry Choi United States 6 16 0.2× 10 0.2× 29 0.6× 72 2.1× 20 0.6× 7 278
L Béraneck France 5 53 0.7× 78 1.4× 21 0.5× 159 4.5× 12 0.4× 18 383
Iman Zaki United Kingdom 9 17 0.2× 25 0.4× 114 2.5× 59 1.7× 83 2.4× 16 256
Zijian Cheng China 6 145 1.9× 8 0.1× 46 1.0× 7 0.2× 15 0.4× 13 318

Countries citing papers authored by Rula Amarin

Since Specialization
Citations

This map shows the geographic impact of Rula Amarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rula Amarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rula Amarin more than expected).

Fields of papers citing papers by Rula Amarin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rula Amarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rula Amarin. The network helps show where Rula Amarin may publish in the future.

Co-authorship network of co-authors of Rula Amarin

This figure shows the co-authorship network connecting the top 25 collaborators of Rula Amarin. A scholar is included among the top collaborators of Rula Amarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rula Amarin. Rula Amarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ibraheem, Akram, et al.. (2025). First Clinical Experience of 68Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls. Diagnostics. 15(2). 218–218. 6 indexed citations
2.
Al‐Ibraheem, Akram, Ahmed Saad Abdlkadir, Hongcheng Shi, et al.. (2025). [177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review. Seminars in Nuclear Medicine. 55(6). 988–998. 2 indexed citations
3.
Amarin, Rula, et al.. (2024). Clinical and Molecular Characteristics and Outcome of Adult Medulloblastoma at a Tertiary Cancer Center. Cancers. 16(21). 3609–3609. 2 indexed citations
4.
Abdlkadir, Ahmed Saad, Rula Amarin, Enrique Estrada-Lobato, & Akram Al‐Ibraheem. (2024). Recurrent sinonasal meningioma: insights from somatostatin receptor imaging. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 43(4). 500014–500014.
5.
Zeidan, Youssef H., Rula Amarin, Samer Deeba, et al.. (2024). 250P Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma: Final analysis of the phase II Averectal trial. Annals of Oncology. 35. S107–S107. 2 indexed citations
6.
Amarin, Rula, et al.. (2024). Quality of life and physical activity levels among colorectal cancer patients: An observational study. Medicine. 103(28). e38778–e38778.
8.
Amarin, Rula, et al.. (2023). Comparing real-world outcomes of total neoadjuvant treatment and CRT at a tertiary medical center. Frontiers in Oncology. 13. 1305322–1305322.
9.
Amarin, Rula, et al.. (2023). Detection of extracranial and intracranial calcified carotid artery atheromas in cone beam computed tomography using a deep learning convolutional neural network image segmentation approach. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 138(1). 162–172. 3 indexed citations
10.
Ababneh, Hazim, et al.. (2022). Sarcoma brain metastases: Tertiary cancer center experience. Journal of Cancer Research and Therapeutics. 19(Suppl 2). S758–S763. 2 indexed citations
11.
Amarin, Rula, et al.. (2022). Acute arterial thrombosis in a colon cancer patient after administration of oxaliplatin with capecitabine chemotherapy “case report”. SHILAP Revista de lepidopterología. 6. 100166–100166. 1 indexed citations
12.
Amarin, Rula, et al.. (2021). Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan. Blood Research. 56(4). 279–284. 1 indexed citations
13.
Abdel‐Razeq, Hikmat, et al.. (2021). The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients. Frontiers in Oncology. 11. 677776–677776. 6 indexed citations
14.
Dey, Amit K., Dhrubajyoti Bandyopadhyay, Raja Zaghlol, et al.. (2020). Periodontal Inflammation and the Risk of Cardiovascular Disease. Current Atherosclerosis Reports. 22(7). 28–28. 116 indexed citations
15.
Hamad, Ahmad, Aatur D. Singhi, Nathan Bahary, et al.. (2017). Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a MetastaticERBB2(HER2)-Amplified Duodenal Cancer. Journal of the National Comprehensive Cancer Network. 15(8). 983–988. 11 indexed citations
16.
17.
Amarin, Rula, et al.. (2013). Contemporary management of perianal conditions in febrile neutropenic patients. European Journal of Surgical Oncology. 39(4). 404–407. 20 indexed citations
18.
Amarin, Rula, et al.. (2011). Eight primary malignancies. Hematology/Oncology and Stem Cell Therapy. 4(4). 185–187. 4 indexed citations
19.
Salem, Ahmed, et al.. (2011). Multiple Primary Malignancies: Analysis of 23 Patients with at Least Three Tumors. Journal of Gastrointestinal Cancer. 43(3). 437–443. 18 indexed citations
20.
Abdel‐Razeq, Hikmat, et al.. (2010). The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center. Hematology/Oncology and Stem Cell Therapy. 3(2). 78–83. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026